Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin-first versus insulin for gestational diabetes: neonatal outcomes trial
IRCT20261021071512N1Phase 3Recruiting
- Sponsor
- Lady Reading Hospital
- Start
- Nov 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin and human insulin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Lady Reading Hospital. Primary endpoints: Neonatal hypoglycemia, Birth weight and 16 more. Started Nov 2026; status: recruiting.
02
Drugs
metforminhuman insulin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on IRCT20261021071512N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20261021071512N1.